We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Method Analyzes Genetic Variations in Families with High Incidence of Breast Cancer

By LabMedica International staff writers
Posted on 11 Nov 2024
Print article
Image: A study has provided new insights into the genetic underpinnings of familial breast cancer (Photo courtesy of 123RF)
Image: A study has provided new insights into the genetic underpinnings of familial breast cancer (Photo courtesy of 123RF)

Breast cancer is the most prevalent type of cancer among women in Western countries, with genetic variants responsible for up to 10% of cases. Hereditary or familial breast cancer accounts for about 15% of all breast cancer cases. Mutations in well-known genes such as BRCA1 and BRCA2 have been associated with an increased risk of familial breast and ovarian cancer, but these genes only explain 30-40% of familial cases. This leaves a significant number of cases with unclear genetic origins, particularly in families with a history of the disease across multiple generations. Despite this, many familial cases remain genetically unexplained due to the complex nature of the genetic factors involved. Now, a study has provided new insights into the genetic causes of familial breast cancer, particularly in families of Middle Eastern descent.

Researchers at The Hebrew University of Jerusalem (Jerusalem, Israel) conducted the study using an advanced method to examine genetic variations in families with a history of breast cancer. This approach combines machine learning with in-depth analysis of protein structures to investigate rare genetic variants. By performing whole genome sequencing and applying AI analysis, the researchers studied genetic variations in women from Middle Eastern families. The study identified significant genetic changes, connecting specific gene subgroups to critical cellular pathways involving peroxisomes, which are involved in fat metabolism. The analysis of 1218 genetic variants from 12 families revealed 80 genes that could have a significant impact on breast cancer risk. Among these, 70 genes had not been previously linked to breast cancer, greatly enhancing our understanding of the disease's genetic basis.

The study, published in Briefings in Bioinformatics, highlighted the importance of certain cellular pathways, particularly those involving peroxisomes and mitochondria, in increasing susceptibility to breast cancer and influencing patient survival. These pathways were particularly relevant across a variety of ethnic groups in seven of the studied families, emphasizing the broader significance of the findings. These discoveries open new possibilities for genetic testing and the development of targeted therapies, which could greatly improve breast cancer management and treatment across diverse populations. Furthermore, these findings may eventually lead to the creation of a specialized genetic testing panel for these groups, improving early detection and personalized treatment strategies as research continues.

"Our research not only sheds light on the elusive genetic factors behind familial breast cancer but also heralds the possibility of new, targeted treatment strategies that could eventually benefit a wider array of patients, particularly those from underrepresented groups," said Prof. Dina Schneidman-Duhovny from the Rachel and Selim Benin School of Computer Science and Engineering at the Hebrew University of Jerusalem who led the study.

New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Automated Blood Typing System
IH-500 NEXT
New
Silver Member
Rubella Infection ELISA
ReQuest RUBELLA IgM ELISA Kit
New
Quantitative Immunoassay Analyzer
AS050

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: SCOPE IO has shown promise in predicting immunotherapy response in rare cancer patients (Photo courtesy of Lunit)

AI-Powered Whole-Slide Image Analyzer Predicts Immunotherapy Response for Rare Cancer Patients

Immunotherapy, especially immune checkpoint inhibitors like pembrolizumab, has become a groundbreaking treatment for cancer patients. However, not all patients respond the same way to this therapy, and... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.